Skip to main content
OpenTrials

Clinical trial condition

Recurrent Neuroblastoma

Explore clinical trials studying Recurrent Neuroblastoma. Study availability and eligibility vary by location and protocol.

55 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Neuroblastoma trial results

Completed

Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma

NCT01334515

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Children's Oncology Group Arcadia, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 76 locations
View Trial Details
Completed

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

NCT00436852

Conditions
Disseminated Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • C S Mott Children's Hospital Ann Arbor, Michigan, United States
View Trial Details
Completed

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

NCT00309907

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +86 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Oncology Group Arcadia, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 26 locations
View Trial Details
Completed

Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma

NCT01208454

Conditions
Localized Unresectable Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 13 locations
View Trial Details

Related conditions